Okay, we know we already introduced y'all to Men's Health Philippines's 100th issue last week, but can we make another recommendation for your next read?
We'd like to hook you up with this month's edition of Esquire Philippines, featuring a very well-written story about the tribunal twists and turns of Erik Matti's Cannes-bound action flick, On The Job, starring these three fine gentlemen on the cover.
We really don't want to spoil everything about this month's cover story (it really, really is a fantastic read), but here are some of the lighter stuff we learned about 2013's most anticipated film:
1. The world's first brush with On The Job was an 8-minute teaser trailer that played during the screening of another Erik Matti-Joel Torre project, The Arrival, at the Cultural Center of the Philippines in 2009. At the time, the movie still didn't have a screenplay.
2. Todd Brown, editor of the influential film webzine Twitch, was the one who encouraged Erik to start writing the screenplay. He also promised to provide potential investors for the project, which unfortunately did not push through by the time the first draft of the script was completed.
3. Star Cinema initially declined to co-produce the project the first time Direk Erik offered, but eventually changed their minds after reading the revised screenplay. By the time the movie was done, the script had gone through a total of 13 revisions.
4. Erik first offered the role of Daniel to Piolo Pascual. Piolo was so impressed by the screenplay that, at one point, he considered also joining in as producer through his own film company, Spring Films.
5. Piolo would be the one responsible for the casting of Gerald Anderson, who ultimately landed the role of Daniel in the film. The two casually talked about collaborating with Matti after meeting up backstage during a fashion show.
NEXT: Casting fiascos and the one actor Erik Matti just won't let go
These crazy battles are over 9000!
Plus, the Nike Hyper Court app is finally here
It's because she's really the cutest
Spoilers ahead—read at your own risk